Title |
The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
|
---|---|
Published in |
Lancet Oncology, July 2020
|
DOI | 10.1016/s1470-2045(20)30388-0 |
Pubmed ID | |
Authors |
Camille Maringe, James Spicer, Melanie Morris, Arnie Purushotham, Ellen Nolte, Richard Sullivan, Bernard Rachet, Ajay Aggarwal |
X Demographics
The data shown below were collected from the profiles of 3,476 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 525 | 15% |
United States | 321 | 9% |
Canada | 74 | 2% |
Spain | 71 | 2% |
Germany | 64 | 2% |
Poland | 42 | 1% |
Australia | 41 | 1% |
Japan | 31 | <1% |
Netherlands | 29 | <1% |
Other | 329 | 9% |
Unknown | 1949 | 56% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3085 | 89% |
Practitioners (doctors, other healthcare professionals) | 172 | 5% |
Scientists | 163 | 5% |
Science communicators (journalists, bloggers, editors) | 48 | 1% |
Unknown | 8 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,291 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1291 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 158 | 12% |
Student > Bachelor | 146 | 11% |
Student > Master | 121 | 9% |
Other | 96 | 7% |
Student > Ph. D. Student | 95 | 7% |
Other | 194 | 15% |
Unknown | 481 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 366 | 28% |
Nursing and Health Professions | 75 | 6% |
Biochemistry, Genetics and Molecular Biology | 48 | 4% |
Social Sciences | 44 | 3% |
Agricultural and Biological Sciences | 25 | 2% |
Other | 185 | 14% |
Unknown | 548 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2940. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 March 2024.
All research outputs
#2,288
of 25,593,129 outputs
Outputs from Lancet Oncology
#4
of 6,920 outputs
Outputs of similar age
#146
of 431,001 outputs
Outputs of similar age from Lancet Oncology
#2
of 94 outputs
Altmetric has tracked 25,593,129 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,920 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 431,001 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.